Protara Therapeutics to Host Conference Call and Webcast to Review Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC on Monday, April 28, 2025

Stock Information for Protara Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.